Dr Chris Jones
Head of Regulatory Governance and Chair of IAG · MHRA
About Dr
Dr Jones is a distinguished regulatory expert and senior leader in health products regulation, currently serving as Head of Regulatory Governance and Chair of the Inspection Action Group (IAG) at the Medicines and Healthcare products Regulatory Agency (MHRA), the UK’s executive agency responsible for ensuring the safety, quality and effectiveness of medicines, medical devices and related healthcare products.
In his dual role, Dr Jones provides strategic leadership across regulatory governance and compliance, while also guiding the MHRA’s IAG, a multidisciplinary panel that advises on inspection outcomes and the escalation of regulatory actions where critical deficiencies are identified following inspection activity. His position sits at the heart of the UK’s system for protecting public health through robust inspection practices that balance scientific rigour with proportionate risk-based decision-making.
Dr Jones brings a deep understanding of inspection methodology, regulatory escalation pathways, and organisational governance, gained through years of experience within regulatory environments. His work focuses on strengthening how inspection findings are interpreted, how regulatory actions are prioritised, and how governance frameworks ensure objective, consistent, and transparent outcomes for regulated entities and wider healthcare systems.
A respected voice among his peers, Dr Jones is recognised for his thoughtful approach to aligning inspection practices with evolving regulatory landscapes, especially in areas where innovation and patient safety intersect. His leadership in governance enhances organisational clarity on compliance expectations and promotes best practices that support both public confidence and regulatory excellence.
In his dual role, Dr Jones provides strategic leadership across regulatory governance and compliance, while also guiding the MHRA’s IAG, a multidisciplinary panel that advises on inspection outcomes and the escalation of regulatory actions where critical deficiencies are identified following inspection activity. His position sits at the heart of the UK’s system for protecting public health through robust inspection practices that balance scientific rigour with proportionate risk-based decision-making.
Dr Jones brings a deep understanding of inspection methodology, regulatory escalation pathways, and organisational governance, gained through years of experience within regulatory environments. His work focuses on strengthening how inspection findings are interpreted, how regulatory actions are prioritised, and how governance frameworks ensure objective, consistent, and transparent outcomes for regulated entities and wider healthcare systems.
A respected voice among his peers, Dr Jones is recognised for his thoughtful approach to aligning inspection practices with evolving regulatory landscapes, especially in areas where innovation and patient safety intersect. His leadership in governance enhances organisational clarity on compliance expectations and promotes best practices that support both public confidence and regulatory excellence.